#Pharma #Brevets #Inde Merck wins Indian injunction against Januvia copycats - FiercePharma http://t.co/603imOLg32
June 26, 2013
Publicité
/http%3A%2F%2Fassets.fiercemarkets.net%2Fpublic%2Fopengraphimages%2Fopengraph_fiercepharma.png)
Merck wins Indian injunction against Januvia copycats
Merck's ($MRK) Indian unit won an injunction in a patent fight over its diabetes drugs Januvia and Janumet, blocking generic versions of the two drugs to be made by Indian drugmaker Aprica Pharmaceuticals. It's one of the few recent patent court decisions there in favor of Big Pharma. Report